Condition: Aortic Regurgitation Disease · Aortic Valve Calcification · Bicuspid Aortic Valve Disease · Sponsor: Instituto Dante Pazzanese de Cardiologia
The VANGUARD study is an open-label, prospective, randomized trial comparing the long-term outcomes of two advanced bioprosthetic aortic valves, Dafodil® and INSPIRIS Resilia®, in patients undergoing aortic valve replacement (AVR). This study aims to provide robust data on valve durability, safety, and hemodynamic performance, particularly in younger patients who may require multiple interventions over their lifetimes.
This description comes directly from the study's public registry record.
Tacianne Rolemberg Delamain, Master Degree · 551150856353 · patricia.paiva@dantepazzanese.org.br
Kleber Gomes Franchini, PhD · 551150856353 · kleber.franchini@dantepazzanese.org.br
Always discuss trial participation with your own doctor first.
| Instituto Dante Pazzanese de Cardiologia | São Paulo, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06688448